NIAID Advanced Technology SBIR (NIAID-at-SBIR [R43/R44])

The summary for the NIAID Advanced Technology SBIR (NIAID-at-SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIAID Advanced Technology SBIR (NIAID-at-SBIR [R43/R44]): Purpose. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for advanced technology projects that require a longer award period and greater award amount than those routinely allowed under the SBIR program. For this FOA, "advanced technology" is defined as a clearly identified product or service that requires approval of the Food and Drug Administration (FDA) and is in one of the following three research areas: A vaccine, biologic, or drug to treat an infectious disease, an immunologic disease, allergy, or transplantation; A vaccine, biologic or drug delivery system; Assays for the diagnosis of an infectious disease, immunologic disease, allergic disease, or as an aid to transplantation, or therapeutic monitoring systems for clinical trials of vaccines, biologics, drugs or transplantation. An example of a clearly identified product is a research project focused on a lead compound for an AIDS drug. A research project focused on developing an assay to identify lead compounds does not have a clearly identified product and would not be appropriate for this FOA. Only applications meeting the above advanced technology definition should be submitted in response to this FOA. Applications in response to this FOA should not contain human clinical trials.
Federal Grant Title: NIAID Advanced Technology SBIR (NIAID-at-SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-09-115
Type of Funding: Grant
CFDA Numbers: 93.855
CFDA Descriptions: Allergy, Immunology and Transplantation Research
Current Application Deadline: Jan 07, 2010
Original Application Deadline: Jan 07, 2010
Posted Date: Feb 27, 2009
Creation Date: Feb 27, 2009
Archive Date: Feb 07, 2010
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Cellular Therapies for Treatment of Radiation Injuries (U01)
International Research in Infectious Diseases, including AIDS (R01)
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
Environmental influences on Placental Origins of Development (ePOD) (R01)
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01) is not endorsed by, or affiliated with, any government agency. Copyright ©2017